Dual Modality CT/X-ray Luminescence CT for in vivo Cancer Imaging ABSTRACT A combined X-ray CT and molecular imaging system, referred to as ?CT/X-ray luminescence CT (XLCT)?, is proposed. The system uses X-ray as a single source to image anatomy and molecular features from simultaneous detection of luminescence signals of X-ray activatable molecular probes. In this technique, the spatial information is obtained by exciting the sample using spatially selective X-ray patterns while optical detectors placed around the sample measure luminescence photons diffusing out. Regardless of where these photons are detected, it is known that they are created somewhere on the path of the coded X-ray beams. This fundamental principle constitutes a new paradigm for imaging deep-seated light-emitting probes, with little background from tissue auto-fluorescence. Another significant advantage of XLCT is that X-ray excitation is amplified by orders of magnitude because of the extremely high quantum yield (2-4 orders of magnitude greater than 100%) of the radioluminescent materials. Toward establishing XLCT for various biomedical applications and eventually for clinical applications, we have assembled a multidisciplinary team consisting of leading investigators with expertise in CT imaging, molecular imaging, biochemistry, medical physics, computational science, and medicine, and established research themes that unify the common interests and expertise of these investigators. If successful, the hybrid CT/XLCT will overcome many of the limitations of CT and optical imaging methods and enable us to visualize biological processes in the anatomical CT image context with unprecedented sensitivity, specificity and spatial resolution. The novel dual modality imaging strategy will therefore significantly advance the field of cancer imaging and provide a valuable imaging tool for biological and clinical studies.

Public Health Relevance

Dual Modality CT/X-ray Luminescence CT for in vivo Cancer Imaging NARRATIVE The goal of this project is to develop a novel dual modality imaging system of CT and X-ray luminescence CT (XLCT) for simultaneous imaging of anatomy and biological features in living subjects. XLCT uses X-ray- activatable molecular probes to obtain biological information while simultaneously providing anatomical CT images. The development promises to impact fundamentally on biomedical imaging research and will lay foundation for human imaging applications in the future.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA227713-01A1
Application #
9667175
Study Section
Biomedical Imaging Technology Study Section (BMIT)
Program Officer
Tata, Darayash B
Project Start
2018-12-01
Project End
2023-11-30
Budget Start
2018-12-01
Budget End
2019-11-30
Support Year
1
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Stanford University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305